Clinical Trials
Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has failed to meet the primary endpoint in its first Phase III trials in cancer pain.
Sativex (nabiximols) is derived from cannabis and usually used to treat the symptoms of multiple sclerosis (MS). This trial was testing the drug for the...
Clinical Trials
TxCell announces start of phase IIb clinical trial with Ovasave(R) for refractory Crohn’s disease
TxCell undertaking one of largest ever controlled studies for a personalized T cell immunotherapy product . Top line results of this study are expected...
Clinical Trials
Sanofi and Regeneron report positive Phase IIb trial results of dupilumab in asthma patients
Sanofi and Regeneron Pharmaceuticals have reported positive results from the interim analysis of a dose-ranging Phase IIb trial of dupilumab, a fully-human monoclonal antibody, in...
Clinical Trials
Sarepta doses first patient in eteplirsen trial to treat duchenne muscular dystrophy
US-based Sarepta Therapeutics has started dosing patients in a clinical trial of its lead exon-skipping therapeutic candidate eteplirsen to treat Duchenne muscular dystrophy (DMD). ...
Clinical Trials
TxCell achieves positive results for Col-Treg in a model of autoimmune uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic candidate in this rare eye disease ...
Clinical Trials
FDA Approves Addition to CIALIS® (tadalafil) Product Label
Eli Lilly and Company announced the U.S. FDA approved a product label addition for CIALIS to include data from a 26-week study that showed CIALIS...
Clinical Trials
The Netherlands-based company Prosena has begun the submission process for drisapersen, its treatment for Duchenne muscular dystrophy (DMD).
The news is a remarkable turnaround for the drug, which had looked doomed to failure just a few months ago. In January this year, GlaxoSmithKline...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.